Outcomes in patients with B-cell precursor acute lymphoblastic leukemia receiving inotuzumab ozogamicin stratified by body mass index.

Authors: Wendy Stock, Ryan Daniel Cassaday, Daniel J. DeAngelo, Anjali S. Advani, Nicola Gökbuget, Jose-Maria Ribera-Santasusana, Wei Jiang, Susana Pulido, Erik Vandendries, Elias Jabbour, Hagop M. Kantarjian

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.6541

Source: Full article

---

Abstract

6541